Stage IVC Squamous Cell Carcinoma of the Oropharynx Completed Phase 2 Trials for Lapatinib (DB01259)

IndicationStatusPhase
DBCOND0029839 (Stage IVC Squamous Cell Carcinoma of the Oropharynx)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00114283Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck CancerTreatment